FEBS Letters · 1987 · 13 citations · 11 references
MedicineMedicinal ChemistryPharmacologyDrug DiscoveryMolecular PharmacologyNeuropharmacologyLigand BindingLipid ChemistryLipid StructureLipid-protein InteractionsReceptor PharmacologyAdenosine Receptor ModulationAdenosine Receptor SignalingFatty AcidsG Protein-coupled Receptor BindingLipidic ProdrugsReceptors
Chemically functionalized congeners of N6-phenyladenosine and 1,3-dipropyl-8-phenylxanthine have been covalently coupled to fatty acids, diglycerides, and a phospholipid. The lipid-drug conjugates inhibit R-[3H]-phenylisopropyladenosine binding to A1-adenosine receptors in rat cerebral cortex membranes. A xanthine-phosphatidylethanolamine conjugate bound with a Ki value of 19 nM. Various xanthine esters of low potency are potential prodrugs. Amides of an adenosine amine congener (ADAC) with 18-carbon fatty acids exhibited Ki values at A1-adenosine receptors of 70 pM, representing a 130-fold enhancement over the affinity of the corresponding acetyl amide. The very high affinity of adenosine-lipid conjugates may be due to stabilization of these adducts in the phospholipid microenvironment of the receptor protein.
11
Macrophages and metastasis--a biological approach to cancer therapy.
Isaiah J. Fidler · PubMed · 1985 · 346 citations
Medicine, Cancer Biology, Oncology +14
Aaron Garzon-Aburbeh, Jacques H. Poupaert, Michel Claesen et al. · Journal of Medicinal Chemistry · 1986 · 99 citations